MGNX
MacroGenics Inc
Price:  
5.55 
USD
Volume:  
630,855.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MGNX EV/EBITDA

-1128.4%
Upside

As of 2024-07-27, the EV/EBITDA ratio of MacroGenics Inc (MGNX) is -1.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MGNX's latest enterprise value is 267.24 mil USD. MGNX's TTM EBITDA according to its financial statements is -163.72 mil USD. Dividing these 2 quantities gives us the above MGNX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 17.3x - 23.3x 20.5x
Forward P/E multiples 21.8x - 25.1x 24.2x
Fair Price (55.76) - (59.68) (57.08)
Upside -1104.6% - -1175.3% -1128.4%
5.55 USD
Stock Price
(57.08) USD
Fair Price

MGNX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-26 -1.63
2024-07-25 -1.61
2024-07-24 -1.52
2024-07-23 -1.55
2024-07-22 -1.55
2024-07-19 -1.39
2024-07-18 -1.43
2024-07-17 -1.46
2024-07-16 -1.57
2024-07-15 -1.36
2024-07-12 -1.31
2024-07-11 -1.29
2024-07-10 -1.14
2024-07-09 -1.14
2024-07-08 -1.13
2024-07-05 -1.12
2024-07-03 -1.12
2024-07-02 -1.08
2024-07-01 -1.15
2024-06-28 -1.13
2024-06-27 -1.09
2024-06-26 -1.07
2024-06-25 -1.15
2024-06-24 -1.23
2024-06-21 -1.18
2024-06-20 -1.09
2024-06-18 -1.09
2024-06-17 -1.15
2024-06-14 -1.22
2024-06-13 -1.30
2024-06-12 -1.42
2024-06-11 -1.40
2024-06-10 -1.26
2024-06-07 -1.24
2024-06-06 -1.30
2024-06-05 -1.39
2024-06-04 -1.18
2024-06-03 -1.22
2024-05-31 -1.07
2024-05-30 -1.13
2024-05-29 -1.09
2024-05-28 -1.17
2024-05-24 -1.25
2024-05-23 -1.28
2024-05-22 -1.31
2024-05-21 -1.14
2024-05-20 -1.14
2024-05-17 -1.18
2024-05-16 -1.47
2024-05-15 -1.31